Among the PPAR isoforms, PPAR-γ activation has been shown to improve insulin sensitivity, reduce renal inflammation, and inhibit profibrotic signaling, thereby attenuating glomerulosclerosis and tubulointerstitial fibrosis in DKD (56). This evidence concerns the gene PPARG and glomerulosclerosis.